Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Current Ratio 2006-2020 | GILD

Current and historical current ratio for Gilead Sciences (GILD) from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Gilead Sciences current ratio for the three months ending June 30, 2020 was 2.33.
  
Gilead Sciences Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-06-30 $24.64B $10.56B 2.33
2020-03-31 $26.95B $8.88B 3.04
2019-12-31 $30.30B $9.76B 3.10
2019-09-30 $28.36B $9.57B 2.96
2019-06-30 $33.73B $8.96B 3.76
2019-03-31 $34.02B $9.40B 3.62
2018-12-31 $35.84B $10.61B 3.38
2018-09-30 $34.92B $10.12B 3.45
2018-06-30 $32.73B $10.91B 3.00
2018-03-31 $30.26B $10.67B 2.84
2017-12-31 $31.82B $11.64B 2.74
2017-09-30 $35.32B $9.60B 3.68
2017-06-30 $28.59B $8.49B 3.37
2017-03-31 $21.42B $8.28B 2.59
2016-12-31 $19.59B $9.22B 2.13
2016-09-30 $21.43B $11.07B 1.94
2016-06-30 $18.35B $10.44B 1.76
2016-03-31 $19.27B $10.91B 1.77
2015-12-31 $24.76B $9.89B 2.50
2015-09-30 $25.91B $9.36B 2.77
2015-06-30 $18.09B $8.93B 2.03
2015-03-31 $20.06B $7.43B 2.70
2014-12-31 $17.71B $5.76B 3.08
2014-09-30 $12.56B $6.06B 2.08
2014-06-30 $15.50B $6.23B 2.49
2014-03-31 $12.97B $5.92B 2.19
2013-12-31 $7.00B $6.41B 1.09
2013-09-30 $6.97B $4.90B 1.42
2013-06-30 $7.07B $4.94B 1.43
2013-03-31 $6.66B $4.29B 1.55
2012-12-31 $6.16B $4.24B 1.45
2012-09-30 $5.88B $4.80B 1.23
2012-06-30 $5.84B $4.99B 1.17
2012-03-31 $5.83B $4.19B 1.39
2011-12-31 $13.92B $2.52B 5.54
2011-09-30 $6.15B $2.22B 2.76
2011-06-30 $6.22B $2.31B 2.69
2011-03-31 $6.85B $2.77B 2.47
2010-12-31 $5.71B $2.47B 2.32
2010-09-30 $6.03B $2.59B 2.33
2010-06-30 $5.71B $3.11B 1.84
2010-03-31 $5.12B $1.89B 2.72
2009-12-31 $4.81B $1.87B 2.57
2009-09-30 $4.30B $1.89B 2.28
2009-06-30 $4.00B $1.78B 2.25
2009-03-31 $4.62B $1.26B 3.66
2008-12-31 $4.28B $1.22B 3.50
2008-09-30 $4.33B $1.26B 3.44
2008-06-30 $3.67B $2.45B 1.50
2008-03-31 $2.95B $0.94B 3.14
2007-12-31 $3.03B $0.74B 4.11
2007-09-30 $2.55B $0.69B 3.68
2007-06-30 $2.45B $0.75B 3.26
2007-03-31 $2.44B $0.71B 3.44
2006-12-31 $2.43B $0.76B 3.18
2006-09-30 $4.03B $0.58B 6.93
2006-06-30 $2.49B $0.51B 4.91
2006-03-31 $3.38B $0.42B 8.00
2005-12-31 $3.09B $0.47B 6.65
2005-09-30 $2.30B $0.27B 8.58
2005-06-30 $2.39B $0.26B 9.13
2005-03-31 $2.07B $0.27B 7.66
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $79.097B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.083B 15.43
Bristol Myers Squibb (BMY) United States $133.476B 10.28
CSL (CSLLY) Australia $94.786B 0.00
Vertex Pharmaceuticals (VRTX) United States $68.716B 38.35
Regeneron Pharmaceuticals (REGN) United States $60.132B 22.99
Biogen (BIIB) United States $43.093B 7.37
Illumina (ILMN) United States $39.858B 46.35
Seattle Genetics (SGEN) United States $31.192B 0.00
Moderna (MRNA) United States $26.500B 0.00
BeiGene (BGNE) Cayman Islands $24.831B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.642B 10.27
Genmab (GMAB) Denmark $23.580B 14.90
Genmab (GNMSF) Denmark $21.776B 5.02
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.715B 0.00
Immunomedics (IMMU) United States $19.687B 0.00
Incyte (INCY) United States $18.802B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.471B 38.54
Alnylam Pharmaceuticals (ALNY) United States $15.598B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioNTech SE (BNTX) Germany $14.442B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.223B 103.20
ARGENX SE-ADR (ARGX) Netherlands $11.557B 0.00
QIAGEN (QGEN) Netherlands $11.554B 29.32
Sarepta Therapeutics (SRPT) United States $11.302B 0.00
Exact Sciences (EXAS) United States $11.165B 0.00
Guardant Health (GH) United States $10.524B 0.00
Bio-Techne Corp (TECH) United States $9.369B 64.28
Galapagos (GLPG) Belgium $8.942B 32.40
Ascendis Pharma (ASND) Denmark $7.715B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $7.643B 19.01
Repligen (RGEN) United States $7.475B 118.65
Exelixis (EXEL) United States $7.329B 26.65
Mirati Therapeutics (MRTX) United States $7.104B 0.00
MyoKardia (MYOK) United States $6.858B 0.00
Acceleron Pharma (XLRN) United States $6.653B 0.00
Adaptive Biotechnologies (ADPT) United States $6.547B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.378B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.224B 0.00
Novavax (NVAX) United States $6.224B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.943B 184.11
Emergent Biosolutions (EBS) United States $5.411B 21.43
Ultragenyx Pharmaceutical (RARE) United States $5.013B 0.00
Blueprint Medicines (BPMC) United States $4.955B 0.00
Zai Lab (ZLAB) China $4.452B 0.00
China Biologic Products (CBPO) China $4.375B 25.97
Vir Biotechnology (VIR) United States $4.247B 0.00
Arena Pharmaceuticals (ARNA) United States $4.194B 0.00
MorphoSys AG (MOR) Germany $4.164B 54.57
NeoGenomics (NEO) United States $3.814B 1151.33
Denali Therapeutics (DNLI) United States $3.752B 0.00
Legend Biotech (LEGN) United States $3.735B 0.00
Bluebird Bio (BLUE) United States $3.705B 0.00
Reata Pharmaceuticals (RETA) United States $3.650B 0.00
Halozyme Therapeutics (HALO) United States $3.546B 0.00
Amicus Therapeutics (FOLD) United States $3.447B 0.00
Insmed (INSM) United States $3.322B 0.00
Principia Biopharma (PRNB) United States $3.319B 0.00
Global Blood Therapeutics (GBT) United States $3.296B 0.00
Fate Therapeutics (FATE) United States $3.167B 0.00
Twist Bioscience (TWST) United States $2.890B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.874B 0.00
Alkermes (ALKS) Ireland $2.677B 56.10
Inovio Pharmaceuticals (INO) United States $2.675B 0.00
I-Mab (IMAB) China $2.391B 0.00
Sorrento Therapeutics (SRNE) United States $2.323B 0.00
PHARMA MAR SA (PHMMF) Spain $2.208B 0.00
Mesoblast (MESO) Australia $2.059B 0.00
Zymeworks (ZYME) Canada $1.983B 0.00
Editas Medicine (EDIT) United States $1.958B 0.00
Seres Therapeutics (MCRB) United States $1.942B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 21.57
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Intra-Cellular Therapies (ITCI) United States $1.843B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.779B 0.00
Revance Therapeutics (RVNC) United States $1.746B 0.00
Eidos Therapeutics (EIDX) United States $1.699B 0.00
UniQure (QURE) Netherlands $1.688B 0.00
Ligand Pharmaceuticals (LGND) United States $1.498B 50.64
Cytokineticsorporated (CYTK) United States $1.486B 0.00
Amarin (AMRN) Ireland $1.419B 0.00
Viela Bio (VIE) United States $1.411B 0.00
Zealand Pharma (ZEAL) Denmark $1.406B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.404B 0.00
Sangamo Therapeutics (SGMO) United States $1.394B 0.00
Beam Therapeutics (BEAM) United States $1.350B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Coherus BioSciences (CHRS) United States $1.300B 7.58
Mersana Therapeutics (MRSN) United States $1.299B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.289B 0.00
Intellia Therapeutics (NTLA) United States $1.238B 0.00
Epizyme (EPZM) United States $1.212B 0.00
Arcus Biosciences (RCUS) United States $1.146B 0.00
Compugen (CGEN) Israel $1.115B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.094B 0.00
NGM Biopharmaceuticals (NGM) United States $1.073B 0.00
REGENXBIO (RGNX) United States $1.066B 0.00
Athenex (ATNX) United States $1.056B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.034B 0.00
Castle Biosciences (CSTL) United States $0.990B 0.00
Arvinas (ARVN) United States $0.963B 0.00
Alcobra (ARCT) United States $0.950B 0.00
Heska (HSKA) United States $0.921B 0.00
Adverum Biotechnologies (ADVM) United States $0.909B 0.00
Myriad Genetics (MYGN) United States $0.900B 0.00
Retrophin (RTRX) United States $0.900B 0.00
Alector (ALEC) United States $0.889B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.830B 0.00
Vericel (VCEL) United States $0.819B 0.00
Cellectis S.A (CLLS) France $0.798B 0.00
Agenus (AGEN) United States $0.787B 0.00
Pliant Therapeutics (PLRX) United States $0.782B 0.00
Morphic Holding (MORF) United States $0.765B 0.00
NantKwest (NK) United States $0.756B 0.00
Protagonist Therapeutics (PTGX) United States $0.752B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
MiMedx (MDXG) United States $0.710B 0.00
Codexis (CDXS) United States $0.697B 0.00
VBI Vaccines (VBIV) United States $0.696B 0.00
Frequency Therapeutics (FREQ) United States $0.685B 0.00
Kadmon Holdings (KDMN) United States $0.659B 0.00
Intrexon (PGEN) United States $0.646B 0.00
Cara Therapeutics (CARA) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Northwest Biotherapeutics (NWBO) United States $0.626B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.571B 0.00
Scholar Rock Holding (SRRK) United States $0.532B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.529B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.528B 0.00
Albireo Pharma (ALBO) United States $0.527B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Geron (GERN) United States $0.522B 0.00
Forte Biosciences (FBRX) United States $0.521B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.521B 4.56
Dynavax Technologies (DVAX) United States $0.496B 0.00
Cel-Sci (CVM) United States $0.494B 0.00
Celldex Therapeutics (CLDX) United States $0.479B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.476B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.473B 0.00
Anika Therapeutics (ANIK) United States $0.463B 20.22
MeiraGTx Holdings (MGTX) United States $0.459B 0.00
IVERIC Bio (ISEE) United States $0.452B 0.00
Kala Pharmaceuticals (KALA) United States $0.447B 0.00
Cue Biopharma (CUE) United States $0.447B 0.00
Pfenex (PFNX) United States $0.436B 0.00
MannKind (MNKD) United States $0.429B 0.00
Starpharma Holdings (SPHRY) Australia $0.428B 0.00
Avid Bioservices (CDMO) United States $0.414B 0.00
UROGEN PHARMA (URGN) United States $0.410B 0.00
Syros Pharmaceuticals (SYRS) United States $0.408B 0.00
AnaptysBio (ANAB) United States $0.404B 0.00
Prothena (PRTA) Ireland $0.404B 0.00
Trevena (TRVN) United States $0.387B 0.00
Amryt Pharma (AMYT) United Kingdom $0.386B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.386B 0.00
Puma Biotechnology (PBYI) United States $0.384B 0.00
Athersys (ATHX) United States $0.377B 0.00
BioDelivery Sciences (BDSI) United States $0.374B 26.50
Sutro Biopharma (STRO) United States $0.371B 0.00
Kamada (KMDA) Israel $0.368B 17.60
WAVE Life Sciences (WVE) Singapore $0.365B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.359B 0.00
Cellular Biomedicine (CBMG) United States $0.354B 0.00
IBio (IBIO) United States $0.354B 0.00
Fortress Biotech (FBIO) United States $0.349B 0.00
ANI Pharmaceuticals (ANIP) United States $0.346B 8.18
AC Immune SA (ACIU) Switzerland $0.344B 0.00
PDL BioPharma (PDLI) United States $0.344B 0.00
Merus (MRUS) Netherlands $0.343B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.307B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.306B 0.00
CytomX Therapeutics (CTMX) United States $0.305B 0.00
Innate Pharma S.A (IPHA) France $0.292B 0.00
Precision BioSciences (DTIL) United States $0.274B 0.00
Cardiff Oncology (CRDF) United States $0.264B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.261B 0.00
Selecta Biosciences (SELB) United States $0.260B 0.00
Affimed (AFMD) Germany $0.252B 0.00
ChromaDex (CDXC) United States $0.252B 0.00
OSMOTICA PHARM (OSMT) United States $0.250B 0.00
Prometic Life Sciences (LMNL) Canada $0.249B 0.00
Cyclerion Therapeutics (CYCN) United States $0.247B 0.00
Arbutus Biopharma (ABUS) United States $0.244B 0.00
Pluristem Therapeutics (PSTI) Israel $0.232B 0.00
NextCure (NXTC) United States $0.226B 0.00
TELA Bio (TELA) United States $0.225B 0.00
Verastem (VSTM) United States $0.212B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
XOMA (XOMA) United States $0.201B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
Dyadic (DYAI) United States $0.198B 0.00
Aduro Biotech (ADRO) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Liquidia Technologies (LQDA) United States $0.185B 0.00
ADMA Biologics Inc (ADMA) United States $0.183B 0.00
Kindred Biosciences (KIN) United States $0.183B 0.00
Biofrontera AG (BFRA) Germany $0.182B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.181B 0.00
Eton Pharmaceuticals (ETON) United States $0.181B 0.00
DBV Technologies S.A (DBVT) France $0.179B 0.00
Cerecor (CERC) United States $0.175B 0.00
Theratechnologies (THTX) Canada $0.173B 0.00
Checkpoint Therapeutics (CKPT) United States $0.173B 0.00
CorMedix Inc (CRMD) United States $0.165B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.162B 7.55
Exicure (XCUR) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.155B 0.00
Aytu Bioscience (AYTU) United States $0.154B 0.00
Aptinyx (APTX) United States $0.152B 0.00
SESEN BIO, INC (SESN) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.147B 0.00
GENFIT S.A (GNFT) France $0.146B 0.00
VolitionRX (VNRX) United States $0.145B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.138B 0.00
Bellus Health (BLU) Canada $0.132B 0.00
AquaBounty Technologies (AQB) United States $0.130B 0.00
Celyad SA (CYAD) Belgium $0.129B 0.00
VTv Therapeutics (VTVT) United States $0.129B 0.00
Applied Genetic Technologies (AGTC) United States $0.126B 0.00
Cidara Therapeutics (CDTX) United States $0.125B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Strongbridge Biopharma (SBBP) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.115B 0.00
Protalix BioTherapeutics (PLX) Israel $0.114B 0.00
Lumos Pharma (LUMO) United States $0.113B 0.00
Palatin Technologies (PTN) United States $0.112B 2.88
Pieris Pharmaceuticals (PIRS) United States $0.110B 0.00
Unum Therapeutics (UMRX) United States $0.106B 0.00
Orgenesis (ORGS) United States $0.105B 5.36
Gritstone Oncology (GRTS) United States $0.105B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.097B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Catalyst Biosciences (CBIO) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.082B 0.00
Oncobiologics (OTLK) United States $0.082B 0.00
Bionano Genomics (BNGO) United States $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Evogene (EVGN) Israel $0.075B 0.00
DiaMedica Therapeutics (DMAC) United States $0.074B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.070B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Curis (CRIS) United States $0.058B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.057B 0.00
Appili Therapeutics (APLIF) Canada $0.056B 0.00
AmpliPhi Biosciences (ARMP) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
TRACON Pharmaceuticals (TCON) United States $0.055B 0.00
Soligenix (SNGX) United States $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Stealth BioTherapeutics (MITO) United States $0.049B 69.75
Novogen (KZIA) Australia $0.048B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
Genetic Technologies (GENE) Australia $0.044B 0.00
Signal Genetics (MGEN) United States $0.044B 0.00
Organovo Holdings (ONVO) United States $0.041B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Vaccinex (VCNX) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
BioCardia (BCDA) United States $0.030B 0.00
OvaScience (MLND) United States $0.029B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Celsion (CLSN) United States $0.024B 0.00
Acorda Therapeutics (ACOR) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.011B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00